Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-018321
Date:2021-03-03
Issuer: INTELLIA THERAPEUTICS, INC. (NTLA)
Original Submission Date:

Reporting Person:

GODDARD GLENN
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET; SUITE 130 CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 57.71 2021-03-03 deemed execution date A 73,500 (a) 2031-03-02 common stock 73,500 $57.71 73,500 direct
RESTRICTED STOCK UNIT 0.0 2021-03-03 deemed execution date A 12,250 (a) common stock 12,250 $0.00 12,250 direct
Footnotes
IDfootnote
f1 this option was granted on march 3, 2021 with respect to 73,500 shares of common stock, with 25% vesting on january 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
f2 on march 3, 2021, the reporting person was granted 12,250 restricted stock units ("rsus") pursuant to the intellia therapeutics, inc. amended and restated 2015 stock option and incentive plan. each rsu represents a contingent right to receive one share of the company's common stock upon vesting, with 25% of the rsu vesting on january 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments.
WhaleWisdom Logo

Elevate your investments